Fluticasone Propionate Nasal Spray Recalled Due to Manufacturing Quality Concerns
Akorn, Inc. is recalling all lots of Fluticasone Propionate Nasal Spray, 50mcg due to manufacturing deviations and inability to verify product stability.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA recall for a medication where manufacturing stability could not be verified due to firm closure and incomplete stability studies. While no illnesses have been reported, medications where safety and efficacy cannot be verified represent a risk-of-harm product per the severity rubric.
Plain-English summary
Akorn, Inc. is recalling all lots of Fluticasone Propionate Nasal Spray, 50mcg in 16-gram bottles distributed nationwide in the United States and Puerto Rico. The product was manufactured by HI-TECH PHARMACAL CO., INC. All lot numbers are included.
The Food and Drug Administration classified this as a Class II recall due to Current Good Manufacturing Practice (CGMP) deviations. The recalling company ceased operations and was unable to complete required stability testing. Stability studies are necessary to ensure medications remain safe and effective throughout their shelf life.
Consumers and healthcare providers who have this product should be aware of the recall. Patients with questions should consult their healthcare provider about their current supply.
The recalled product
- Product
- Fluticasone Propionate Nasal Spray, 50mcg, 16 g bottles, Manufactured by: HI-TECH PHARMACAL CO., INC., Amiy. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · stability unverified
See all →- ModerateAkorn Recalls Cromolyn Sodium Ophthalmic Solution Over Stability Studies
FDA (Drugs) · 2023-06-07
- ModerateFerrous Sulfate Iron Supplement Drops Recalled for Manufacturing Stability Issues
FDA (Drugs) · 2023-06-07
- HighTrihexyphenidyl Hydrochloride Oral Solution Recalled for Unverified Stability
FDA (Drugs) · 2023-06-07
- HighNeomycin and Polymyxin B Eye Ointment Recalled for Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighClobetasol Propionate Ointment recalled due to manufacturing compliance failures
FDA (Drugs) · 2023-06-07
Similar recalls
- ModerateAkorn Recalls Fluticasone Nasal Spray Due to Preservative Failure
FDA (Drugs) · 2015-03-11
- HighFluticasone Propionate Nasal Spray Recalled Due to Defective Container
FDA (Drugs) · 2022-07-06
- HighApotex Recalls Fluticasone Propionate Nasal Spray Due to Glass Particles
FDA (Drugs) · 2018-06-13
- ModerateFluticasone Propionate Nasal Spray Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighFluticasone Propionate Nasal Spray Recalled for Potential Bacterial Contamination
FDA (Drugs) · 2024-02-28
- HighFDA Recalls Fluticasone Propionate Nasal Spray Due to Suspected Bacterial Contamination
FDA (Drugs) · 2024-03-06